BRIEF-FDA grants orphan drug exclusivity to Spectrum Pharmaceutical's Evomela(tm) By: Reuters: Company News April 20, 2016 at 07:26 AM EDT * FDA grants orphan drug exclusivity to Evomela(tm) (melphalan) for injection, indicated for multiple myeloma Read More >> Related Stocks: Spectrum Pharma Inc